BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7340948)

  • 1. Protection by 3-amino-1,2,4-triazole against the lowered uptake of p-biphenylmethyl-(dl-tropyl-alpha-tropinium) bromide into the hepatic lysosomes of carbon tetrachloride-treated mice.
    Matsumoto Y; Suga T
    Chem Pharm Bull (Tokyo); 1981 Dec; 29(12):3617-23. PubMed ID: 7340948
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetics of the in vitro binding of a quaternary ammonium compound (p-biphenylmethyl-(dl-tropyl-alpha-tropinium)bromide (BTTB)) to lysosomes and other subcellular membranes of rat liver.
    Matsumoto Y; Suga T
    Chem Pharm Bull (Tokyo); 1984 Apr; 32(4):1503-9. PubMed ID: 6467459
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological fate of tritiated p-biphenylmethyl-(dl-tropyl-alpha-tropinium)-bromide in the rat.
    Suga T; Nikawa K; Hashimoto T; Izayama H
    Chem Pharm Bull (Tokyo); 1971 Nov; 19(11):2235-40. PubMed ID: 5169411
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of 3-amino-1,2,4-triazole on carbon tetrachloride-induced necrosis.
    Ishii H; Suga T; Ninobe S; Inatsu Y
    Chem Pharm Bull (Tokyo); 1977 Aug; 25(8):2035-40. PubMed ID: 922985
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of 3-amino-1,2,4-triazole treatment on catalase activity and triglyceride level in fatty liver of the rat.
    Ishii H; Suga T; Ninobe S
    Biochem Pharmacol; 1977 Apr; 26(7):625-8. PubMed ID: 856192
    [No Abstract]   [Full Text] [Related]  

  • 6. Modifying effect of 3-amino-1,2,4-triazole on phenobarbital-induced changes in rat liver.
    Stenger RJ; Johnson EA
    Exp Mol Pathol; 1972 Apr; 16(2):147-57. PubMed ID: 5014078
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolism of quaternary ammonium compounds. II. Microautoradiographic studies on the effect of CCl4 on the intralobular distribution of tritiated BTTB in mice liver.
    Matsumoto Y; Takebe Y; Suga T; Niinobe S
    Chem Pharm Bull (Tokyo); 1974 Dec; 22(12):2861-5. PubMed ID: 4468109
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of 3-amino-1,2,4-triazole on the formation of triglyceride in liver slice.
    Ishii H; Suga T; Niinobe S; Inatsu Y
    Chem Pharm Bull (Tokyo); 1977 Sep; 25(9):2283-6. PubMed ID: 589725
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of various basic compounds on the degradation of formaldehyde-treated 125I-labeled bovine serum albumin in mouse liver lysosomes.
    Matsumoto Y; Suga T
    Biochem Med Metab Biol; 1987 Apr; 37(2):220-7. PubMed ID: 3593593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of 3-amino-1,2,4-triazole on hepatic and renal deiodination of L-thyroxine to 3,5,3'-triiodothyronine.
    Scammell JG; Fregly MJ
    Toxicol Appl Pharmacol; 1981 Aug; 60(1):45-51. PubMed ID: 7281174
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of argentosomes, a type of secondary lysosomes, and the sub-organellar distribution of a lysosomotropic basic compound.
    Matsumoto Y; Watanabe T; Suga T; Fujitani H
    J Pharmacobiodyn; 1988 Oct; 11(10):679-84. PubMed ID: 3221300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of quaternary ammonium compounds on lysosomal degradation of endogenous proteins.
    Matsumoto Y; Watanabe T; Suga T; Fujitani H
    Chem Pharm Bull (Tokyo); 1989 Feb; 37(2):516-8. PubMed ID: 2743503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 3-amino-1,2,4-triazole on in vivo formation of liver triglyceride.
    Ishii H; Suga T; Niinobe S
    Biochem Pharmacol; 1977 Jul; 26(13):1255-8. PubMed ID: 880271
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition by 3-amino-1,2,4-triazole of fatty acid synthesis in cell free system.
    Ishii H; Nakagawa Y; Suga T; Niinobe S
    Chem Pharm Bull (Tokyo); 1978 Sep; 26(9):2674-8. PubMed ID: 699209
    [No Abstract]   [Full Text] [Related]  

  • 15. [Disorder of the heterophage function of rat liver lysosomes in acute and chronic toxic hepatitis].
    Korolenko TA; Titova VG; Kondakova AE
    Farmakol Toksikol; 1974; 37(6):725-7. PubMed ID: 4464108
    [No Abstract]   [Full Text] [Related]  

  • 16. Irreversible inactivation of catalase by 3-amino-1,2,4-triazole.
    Darr D; Fridovich I
    Biochem Pharmacol; 1986 Oct; 35(20):3642. PubMed ID: 3768046
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of clofibrate and 3-amino-1,2,4-triazole on liver catalase and lipid metabolism in mice.
    Jones GL; Neill AR
    Biochim Biophys Acta; 1982 Aug; 712(2):420-6. PubMed ID: 7126616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of phospholids on liver damage. I. Carbontetrachloride poisoning and alterations in amino acid uptake, peroxidation, sialic acid content, and lysosomal enzymes.
    Gerber GB; Bartsch GG; Deroo J
    Acta Hepatogastroenterol (Stuttg); 1975 Jun; 22(3):175-80. PubMed ID: 1220510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of catalase with 3-amino-1,2,4-triazole: an indirect irreversible mechanism.
    Williams RN; Delamere NA; Paterson CA
    Biochem Pharmacol; 1985 Sep; 34(18):3386-9. PubMed ID: 4038347
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of cytochrome P-450 in carbon tetrachloride activation and CCl 4-induced necrosis. Effect of inhibitors of heme synthesis. I. 3-Amino-1,2,4 triazole.
    D'Acosta N; Castro JA; Díaz Gòmez MI; de Ferreyra EC; de Castro CR; de Fenos OM
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):175-83. PubMed ID: 4733995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.